International, Randomized, Placebo-Controlled, Double-Blind Phase III Study of Motesanib Plus Carboplatin/Paclitaxel in Patients With Advanced Nonsquamous Non–Small-Cell Lung Cancer: MONET1

International, Randomized, Placebo-Controlled, Double-Blind Phase III Study of Motesanib Plus Carboplatin/Paclitaxel in Patients With Advanced Nonsquamous Non–Small-Cell Lung Cancer: MONET1 / Giorgio V., Scagliotti; Ihor, Vynnychenko; Keunchil, Park; Yukito, Ichinose; Kaoru, Kubota; Fiona, Blackhall; Robert, Pirker; Rinat, Galiulin; Tudor Eliade, Ciuleanu; Oleksandr, Sydorenko; Mircea, Dediu; Zsolt Papai, Szekely; Natividad Martinez, Banaclocha; Sheryl, Mccoy; Bin, Yao; Yong jiang, Hei; Galimi, Francesco; David R., Spigel. - In: JOURNAL OF CLINICAL ONCOLOGY. - ISSN 0732-183X. - 30:23(2012), pp. 2829-2836. [10.1200/JCO.2011.41.4987]